AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Jul 28, 2010
34023_dirs_2010-07-28_1f2b6875-b4d8-4b89-af70-aa94f8e2c9c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-07-26
Reporting Person: Valentine Karen (VP and General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-07-26 | Common Stock | A | 2500 | $0.79 | Acquired | 56491 | Direct |
Footnotes
F1: Represents settlement of restricted stock awarded on January 26, 2010.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23